Cédric Charrier
Impact in
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- Histone Deacetylase Inhibitors Research 6
- Cancer therapeutics and mechanisms 5
- Protein Degradation and Inhibitors 4
- Genomics and Phylogenetic Studies 4
- Gut microbiota and health 3
- Oncology 7
- Peptidase Inhibition and Analysis 7
- Co-authors
- Thomas Clavel (6 shared papers)Dirk Haller (6 shared papers)Mareike Wenning (3 shared papers)Michaël Blaut (2 shared papers)Philìppe Bertrand (7 shared papers)Joëlle Roche (4 shared papers)Jean‐Pierre Gesson (4 shared papers)Annett Braune (1 shared paper)
- Journals
- INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY (4 papers)Journal of Antimicrobial Chemotherapy (3 papers)Antimicrobial Agents and Chemotherapy (3 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Tetrahedron (2 papers)
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
Cédric Charrier
31 papers receiving 712 citations
Peers
Comparison fields: 5 of 101
- Molecular Medicine 66
- Microbiology 5
- Molecular Biology 407
- Applied Microbiology and Biotechnology 10
- Toxicology 18
Countries citing papers authored by Cédric Charrier
This map shows the geographic impact of Cédric Charrier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cédric Charrier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cédric Charrier more than expected).
Fields of papers citing papers by Cédric Charrier
This network shows the impact of papers produced by Cédric Charrier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cédric Charrier. The network helps show where Cédric Charrier may publish in the future.
Co-authors
The 25 scholars most cited alongside Cédric Charrier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 86 | |
| 2 | 2009 | 82 | |
| 3 | 2005 | 65 | |
| 4 | 2009 | 55 | |
| 5 | 2014 | 53 | |
| 6 | 2014 | 53 | |
| 7 | 2009 | 42 | |
| 8 | 2017 | 37 | |
| 9 | 2020 | 28 | |
| 10 | 2013 | 22 | |
| 11 | 2016 | 22 | |
| 12 | 2020 | 18 | |
| 13 | 2011 | 18 | |
| 14 | 2006 | 17 | |
| 15 | 2014 | 17 | |
| 16 | 2010 | 17 | |
| 17 | 2018 | 16 | |
| 18 | 2007 | 15 | |
| 19 | 2012 | 13 | |
| 20 | 2014 | 7 |
About Cédric Charrier
Cédric Charrier is a scholar working on Molecular Biology, Oncology, Food Science, Organic Chemistry and Public Health, Environmental and Occupational Health, having authored 32 papers that have together received 727 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (7 papers), Histone Deacetylase Inhibitors Research (6 papers), Cancer therapeutics and mechanisms (5 papers), Probiotics and Fermented Foods (5 papers), Protein Degradation and Inhibitors (4 papers), Genomics and Phylogenetic Studies (4 papers), Streptococcal Infections and Treatments (3 papers) and Gut microbiota and health (3 papers). The work is most often cited by research in Molecular Medicine (66 citations), Microbiology (5 citations), Molecular Biology (407 citations), Applied Microbiology and Biotechnology (10 citations) and Toxicology (18 citations). Cédric Charrier has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Thomas Clavel, Dirk Haller, Mareike Wenning, Michaël Blaut, Philìppe Bertrand, Joëlle Roche, Jean‐Pierre Gesson, Annett Braune, Laura Hanske and Caroline M. Plugge. Their work appears in journals such as INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, Bioorganic & Medicinal Chemistry Letters and Tetrahedron.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.